Opioid Risk Assessment Tool For Females

Assesses a woman’s likelihood of future opioid misuse based on personal history, psychiatric factors, and other validated risk predictors.

Family history of alcohol abuse?
No0Yes+1
Family history of illegal drugs abuse?
No0Yes+2
Family history of prescription drugs abuse?
No0Yes+4
Personal history of alcohol abuse?
No0Yes+3
Personal history of illegal drugs abuse?
No0Yes+4
Personal history of prescription drugs abuse?
No0Yes+5
Age (16-45 years old?)
No0Yes+1
History of preadolescent sexual abuse?
No0Yes+3
ADHD/ADD, OCD, Bipolar, Schizophrenia?
No0Yes+2
Depression?
No0Yes+1

Indications for Use

Used before initiating chronic opioid therapy in women to estimate risk of future aberrant opioid behaviors and guide intensity of monitoring. Helps identify patients needing closer follow‑up, limited quantities, or additional safety strategies such as PDMP review and urine drug testing (NCCN Adult Cancer Pain Guidelines 1 [Level I evidence]). Assists clinicians in tailoring opioid prescribing and mitigating misuse risk.

Insights & Cautions

Begin by recognizing that risk scoring in women can overestimate risk when psychiatric symptoms or prior trauma are present and underestimate risk related to prescription exposure patterns. Most validation studies show variable sensitivity (0.37–0.89) and moderate specificity (0.68–0.83) in female cohorts 1 [Level II evidence]. Use scores only as screening adjuncts; confirm with clinical history, psychiatric comorbidity assessment, and review of prescription monitoring data.